Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker for Hereditary AngioEdema Disease: An International, Multicenter, Longitudinal Monitoring Protocol

NCT03029728 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.

NCT NCT03029728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03029728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker for Hereditary AngioEdema Disease: An International, Multicenter, Longitudinal Monitoring Protocol
Lead sponsor
CENTOGENE GmbH Rostock
Phase
Observational
Overall status
Completed
Start date
August 20, 2018
Completion date
March 11, 2022
Enrollment
42 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

angio edema, c1 esterase inhibitor deficiency, c4 deficiency, hae, hereditary angioedema, hereditary angioedema type i, hereditary angioedema type ii, hereditary angioedema type iii